Nitric oxide (NO) is synthesised from L-arginine by the enzyme NO synthase (NOS). The complex reaction involves the transfer of electrons from NADPH, via the flavins FAD and FMN in the carboxy-terminal reductase domain, to the haem in the amino-terminal oxygenase domain, where the substrate L-arginine is oxidised to L-citrulline and NO. The haem is essential for dimerisation as well as NO production. The pteridine tetrahydrobiopterin (BH ) is a key feature of NOS, affecting dimerisation and electron transfer, although its full 4 role in catalysis remains to be determined. NOS can also catalyse superoxide anion production, depending on substrate and cofactor availability. There are three main isoforms of the enzyme, named neuronal NOS (nNOS), inducible NOS (iNOS), and endothelial NOS 21 (eNOS), which differ in their dependence on Ca , as well as in their expression and activities. These unique features give rise to the distinct subcellular localisations and mechanistic features which are responsible for the physiological and pathophysiological roles of each isoform.
Introduction
The complexity of NOS, with its distinct domains, its multitude of cofactors and prosthetic groups, and its Nitric oxide (NO), synthesised by the enzyme NO unique reaction mechanism, has in recent years drawn the synthase (NOS), is a major factor in the cardiovascular attention of a large number of biochemists and structural system. Its multiple roles include regulation of vasomotor biologists. However, despite intense research efforts, sevtone [1] and cell adhesion to the endothelium [2] , and eral key features remain to be determined, most notably the inhibition of platelet aggregation [3] and vascular smooth structure of the intact enzyme. Other open questions muscle cell proliferation [4] . At first glance, this list would include the complex role of the pterin cofactor tetrahydroappear to suggest that NO is a crucial factor in the biopterin (BH ), the nature of the NOS products in vivo, 4 prevention of cardiovascular damage such as that seen in and the mechanistic reasons for the subtle differences atherosclerosis. Indeed, the loss of endothelial-derived NO between the three isoforms. Recent progress that has been arising from endothelial dysfunction is now thought to be a made towards these goals will be discussed. major cause of such pathological conditions. However, too much of a good thing should usually be avoided, and NO is no exception. Excess or inappropriate production of NO 2. Overview of the NO synthase family can be equally as deleterious as insufficient NO.
Hence, immense research efforts are currently being NOS (EC 1.14.13.39) catalyses NO biosynthesis via a made to understand the regulation, production, and funcreaction involving the conversion of L-arginine to L-citrultions of NO. This review will concentrate on what is line [5] . The enzyme functions as a dimer consisting of currently known about the enzyme which synthesises NO. two identical monomers, which can be functionally (and structurally) divided into two major domains: a C-terminal reductase domain, and an N-terminal oxygenase domain ( Fig. 1 ) [6] . The former contains binding sites for one molecule each of NADPH, FAD, and FMN, in close homology with cytochrome P-450 reductase, whereas the the conditions [13] [14] [15] . The nature of the in vivo products of NOS is still under debate and is discussed in Section 7, latter binds haem and BH , as well as the substrate 4 as well as elsewhere in this issue. L-arginine. Between these two regions lies the calmodulin (CaM) binding domain, which plays a key role in both the structure and function of the enzyme.
4. The reductase and oxygenase domains There are three distinct isoforms of NOS which differ both in their structure and function [7] . Endothelial NOS The isolated reductase domain is able to transfer elec-(eNOS or NOS III, 23134 kDa) and neuronal NOS (nNOS trons from NADPH via the flavins FAD and FMN to or NOS I, 23160 kDa) are generally referred to as 21 cytochrome c, while the oxygenase domain dimer can constitutively expressed, Ca -dependent enzymes, al-
convert the reaction intermediate N -hydroxy-L-arginine to though eNOS can also be activated in a Ca -independent NO and L-citrulline [16] [17] [18] . Hence, the two domains manner (discussed in Section 8.1) [8] . Inducible NOS perform catalytically distinct functions. While the reduc-(iNOS or NOS II, 23130 kDa) is expressed at high levels tase domain itself is highly homologous to enzymes such only after induction by cytokines or other inflammatory as the NADPH:cytochrome P450 reductase, its dependence agents, and its activity is independent of an increase in 21 on the CaM-binding domain for efficient electron transfer Ca . The three NOS isoforms are characterised by is unique [19] . The cofactor binding sites have been regions of high homology, namely the oxygenase and well-defined as a result of the close homology with related reductase domains, but at the same time each isoform reductases as well as evidence obtained from mutagenesis exhibits distinctive features which reflect their specific in studies [20] [21] [22] . In contrast, the binding sites for L-arvivo functions. Although the molecular biology of these ginine, haem, and BH in the oxygenase domain are less isoforms is discussed at length in another article in this 4 well characterised, although several residues have been issue, the main structural differences between the three identified which are important for BH binding (C99 in enzymes will be referred to briefly in a later section of this 4 eNOS [23] , G450 and A453 in iNOS [24] ). A polypeptide article, since they have a major impact on the enzymatic of this region (558-721 in rat nNOS) which shows function of each isoform. similarity to the pterin-binding domain of dihydrofolate reductase and to a region in aromatic amino acid hydroxylases [24] , was however unable to bind BH , but could 3. The NOS-catalysed reaction 4 G bind N -nitro-L-arginine [25] . Two residues important for Biosynthesis of NO involves a two step oxidation of L-arginine binding have been identified in this region: L-arginine to L-citrulline, with concomitant production of E371 and D376 in iNOS [26] , and the analogous E361 in NO (Fig. 2) . The reaction consumes 1.5 mol of NADPH, eNOS [27] . Several other acidic residues which affect and 2 mol of oxygen per mol of L-citrulline formed. The L-arginine and BH binding were also identified in this 4 proposed mechanisms are discussed at length by Griffith region [26] . The loss of L-arginine binding by the E371 and Stuehr and others [9] [10] [11] , and involve an initial mutant was put to good use in a study of electron transfer hydroxylation of L-arginine, leading to the formation of in heterodimers consisting of a full length subunit and an G N -hydroxy-L-arginine, which can also act as a substrate oxygenase domain [28] . NO was synthesised when the for NOS. This is followed by oxidation of the intermediate, oxygenase domain containing the mutation was in the using a single electron from NADPH [12] , to form Lsame subunit as the reductase but not if it was in the citrulline and NO. Although this scheme represents the opposite oxygenase domain, indicating that electrons are reaction assumed to be catalysed by NOS, the enzyme is transferred from the reductase domain flavins on one also capable of catalysing the production of additional subunit to the oxygenase domain haem on the second
products, notably superoxide anion (O ), depending on subunit.
The recently solved crystal structure of a dimeric iNOS oxygenase truncation mutant (residues 66-498) revealed a structure which is unusual for haem-binding proteins in that it contains a large amount of b-sheet [29] . The authors describe the structure in analogy with a baseball glove, with the haem cradled between the proximal 'thumb' and the distal 'palm'. BH binds on the proximal side, while 4 L-arginine is located on the distal side. Another notable feature of the oxygenase domain dimer, revealed in the recent crystal structure of the eNOS haem domain [30] , is the presence of a zinc atom which is tetrahedrally coordinated to two pairs of Cys residues. The metal may be important in determining the stereospecificity of the BH 4 binding site.
The reductase and oxygenase domains of NOS are therefore distinct catalytic units, which together provide the complete machinery required for NO production. This raises the question as to why the functional enzyme is a dimer rather than a monomer. The mutation experiments described above, showing that electrons are transferred from one subunit to another rather than within one subunit, provide a hint to this puzzle. The next section describes the factors important in the dimerisation process which leads NO and O (c). At high BH levels, the enzyme acts purely as an NO 5. The NO synthase dimer 2 4 synthase (d).
An essential feature of NOS is that, despite the ability of the reductase and oxygenase domains to function indepenthe identity of which is known for all three isoforms dently under certain circumstances, NO synthase activity is [34] [35] [36] . The formation of this bond has been suggested to carried out by the homodimer. Although the mechanistic be a key step in the process of dimerisation [37] . Evidence reasons have not yet been resolved in detail, a significant obtained from studying the fluorescence dynamics of amount is already known about the factors which govern nNOS-bound flavins suggests that the haem is also essendimerisation.
tial in the interaction between the reductase and oxygenase domains [38] , which form an interface in the quaternary 5.1. Role of haem structure. The coordination state of the haem can be unequivocally The haem plays an essential role in dimerisation (Fig. identified through examination of the absorption spectrum. 3). In its absence, NOS exists as monomers which are This depends upon the energetical 'spin state' of the essentially normal with respect to secondary structure. unpaired electrons of the haem iron, which in turn is Furthermore, the ability to catalyse the NADPH-dependent related to the geometry of the haem ligands. When these reduction of cytochrome c is retained in nNOS monomers, electrons are in the low-spin state, reflecting a six-coordiindicating that the transfer of electrons within the reductase nate haem, the maximum is observed at 394-397 nm. This domain from NADPH via the two flavins is not dependent form of NOS is inactive. Upon binding L-arginine and its on the dimeric structure [31] . Monomers of all the analogues, as well as BH [39] [40] [41] [42] [43] [44] [45] [46] [47] , the maximum shifts to 4 isoforms are, however, unable to bind BH or a substrate 418 nm, indicative of a high-spin five-coordinate haem, 4 analogue and do not catalyse L-citrulline / NO production which is necessary for NOS activity. [31] [32] [33] . Haem is the sole cofactor for which there is an absolute requirement for the formation of active nNOS 5.2. Role of BH 4 dimers [31] , and it is also the key factor in eNOS dimerisation [33] . Although the characteristics differ from
The haem requirement for dimerisation is common to all those of the two constitutive isoforms, the haem plays a three NOS isoforms. They do however differ with respect similarly essential role in iNOS dimerisation [32] .
to the role of BH in dimerisation. Whereas nNOS and 4 Resolution of the crystal structure confirmed that the eNOS can form dimers in the absence of BH [48] , iNOS pteridine [32] , although dimers were formed in E. coli in also important factors, with their relative contribution the absence of BH [49] . Furthermore, BH stabilises the differing depending on the isoform in question. As a result 4 4 nNOS and eNOS dimers once formed, and also the iNOS of their stabilising interactions, these molecules endow the dimer, although not to the same extent [33, 48, 50, 51] .
NOS dimer with an exceptionally stable quaternary strucThese data are supported by the reduced binding of BH ture. 4 by an N-terminal deletion mutant of iNOS, demonstrating the importance of residues 66-114 in iNOS for binding of the cofactor and hence dimerisation [52] . The recent crystallographic data also show the location of BH at the 6. Calcium dependence and the role of calmodulin 4 dimer interface [29] . Although these observations have had 21 an impact on in vitro synthesis and reconstitution experiDependence on Ca is a key distinguishing feature ments, the functional implications remain uncertain. The between the constitutive and inducible isoforms. eNOS and close resemblance of 4-amino-BH , a novel pterin-based nNOS are both activated by an elevation in intracellular
inhibitor of NOS [51, 53] , to BH in terms of conformaCa , followed by the subsequent binding of Ca / CaM. 4 tional changes induced (low-spin to high-spin conversion In contrast, iNOS contains irreversibly bound CaM, and is 21 of the haem, dimer stabilisation, increased affinity for hence largely independent of Ca , although a 2-fold L-arginine) despite the inability to support NO production greater activity is observed in the presence of 2. does not appear to provide electrons for the reaction [56] . Hence, only the Ca -bound conformation of CaM can 21 In this respect, the role of BH in NOS differs from that in activate the enzyme. This dependence on Ca may be 4 aromatic amino acid hydroxylation [57] . A thorough ultimately due to the presence of an autoinhibitory seanalysis of the interaction of numerous pterins with iNOS quence which is present in the FMN-binding region of the 21 revealed that the steps up to and including haem reduction two Ca -dependent isoforms but is not found in iNOS are supported by dihydropterins as well as tetrahydro- [61] . The CaM-binding region in eNOS is directly inpterins [58] . However, only the latter are able to support volved in membrane association, specifically to anionic NO synthesis and NADPH oxidation. The role of BH in phospholipids such as phosphoserine, and this association 4 electron transfer therefore remains to be settled, although it prevents the binding of CaM to eNOS and hence catalytic has been shown that the cofactor accelerates the decay of activity [62] . CaM binds to both the isolated reductase the ferrous-dioxy complex of nNOS, providing a novel domain of nNOS as well as to the full-length enzyme, and hint to its role in NO synthesis [59] . Despite these clues, stimulates the rate of electron transfer within the reductase the full role of BH in NOS catalysis remains to be domain [19] . CaM is furthermore essential for the transdo- Binding of L-arginine to iNOS facilitates dimerisation [32] . Various arginine analogues as well as compounds containing the guanidinium moiety are also able to facili-7. Products of the reactions catalysed by NO synthase tate iNOS dimerisation [44] . Despite the inability to support NO synthesis, these compounds also alter the nNOS is capable of producing not only NO, but also ?2 heme spin state, indicating a change in the haem geometry O , and peroxynitrite (Fig. 3) . This unusual property is a 2 to the five-coordinate conformation, and increase the rate consequence of the dimeric nature of the enzyme, in which of NADPH oxidation, showing that occupation of the the two subunits are able to function independently [64] . In guanidinium-binding site in the enzyme alters electron fact, the purified nNOS dimer normally consists of one flow. The extensive interactions of L-arginine, as revealed BH -containing subunit and one BH -free subunit, due to 4 4 by the crystal structure [29] , with hydrophilic side chains the large difference in binding affinity between the first of the alpha helix involved in dimer formation, as well as and second BH -binding sites [47] . This negative 4 with the haem propionate which hydrogen bonds to BH , cooperativity of BH binding means that only one subunit 4 4 provide the structural reasons for the stabilising effect on will have BH bound over a wide range of BH con- 4 4 the dimer. centrations (up to 1 mM). This has important implications In summary, the key to dimerisation of NOS lies in the for the outcome of the catalytic reaction, since only at very haem prosthetic group, although BH and L-arginine are high BH concentrations will NOS function purely as an NO synthase (Fig. 3d) . Although the following discussion treated endothelial cells [74] . The reason for this alteration smooth muscle cell proliferation, and leukocyte adhesion, BH -free subunits respectively (Fig. 3c) . Although these 4 which are evident in vascular pathologies are likely to be two products can react together extremely rapidly to form mediated by the scavenging of NO. Evidence for the the potent oxidant peroxynitrite [77] , the physiological
damaging role played by O is provided by the protective outcome probably depends on the levels of GSH and SOD 2 effect of superoxide dismutase (SOD) delivery in a rat [78] . In the absence of these two molecules, peroxynitrite model of angiotensin II-induced hypertension [66] as well is formed. Free NO, which appears to feedback inhibit as in cholesterol-fed rabbits [67, 68] .
nNOS [79] by forming a ferrous-nitrosyl complex [80] , is The only major difference between the NOS isoforms in not detectable unless high concentrations of SOD are terms of the reactions performed lies in the rate of this present [81] . However, very low levels of SOD are NADPH oxidation, termed the uncoupled reaction. Under sufficient to allow enough NO to be formed to activate these conditions, nNOS continues to transfer electrons to soluble guanylate cyclase, although the NO levels are the haem and hence oxidise NADPH at a high rate, below the limits of detection. In the presence of GSH and ?2 whereas in eNOS and iNOS, this reaction occurs at a much SOD, NO / O reacts preferentially with the thiol to form 2 slower rate [33, 40, 63] . A mechanistic explanation for this the thionitrite GSNO, which is likely to act as a storage or difference is provided by a study examining the reduction transport form of NO [82, 83] . Subsequent release of NO potential of the haem [69] . The haem iron in nNOS has a can be mediated by both enzymatic and non-enzymatic significantly higher reduction potential than that in iNOS, mechanisms, although the actual physiological route has which must first bind substrate and BH in order to not yet been clarified. NO-mediated NMDA toxicity in cortical neurons [70] sis [84] , using the presence of the marker nitrotyrosine as indicates that the uncoupled reaction catalysed by nNOS is evidence. However, the true identity of the molecule pathologically relevant. The much lower rate at which this responsible for the tyrosine nitration has recently been put reaction is catalysed by iNOS, which is often present in into question, with the demonstration that peroxynitrite
situations where L-arginine is limited, for example in formed from the simultaneous production of NO and O 2 wounds [71] , has been suggested to constitute a substrateat physiological pH is unable to efficiently nitrate tyrosine
controlled safety mechanism to minimise O production [85] . NO has been proposed as a possible alternative, 2 2 under such conditions [63] . However, recent data has with the demonstration that, in human polymorphonuclear 2 shown that iNOS is in fact capable of catalysing substanneutrophils, NO is converted by myeloperoxidase into the 2 ?2 tial O production [72] . This occurs via a different nitrating and chlorinating species NO Cl and NO [86] . 2 2 2 mechanism to that in nNOS, in that production is catalysed Therefore NOS can, in vitro, act as a peroxynitrite by the reductase domain and is only inhibitable by very synthase. However, the name is unlikely to be applicable high concentrations of L-arginine. A similar control mechain vivo, given the ubiquitous presence of GSH and / or nism for eNOS has been proposed, since the production of SOD, which will react with the NOS products, thereby
O would be highly detrimental in the vasculature [40] . preventing the formation of peroxynitrite. The ability to
However, increased O production by eNOS has been catalyse the production of O is not, as was previously 2 2 described in the context of the endothelial dysfunction seen thought, limited to nNOS, and may in fact be pathologicalin spontaneously hypertensive rats [73] and native LDLly highly relevant.
Unique features of the NO synthase isoforms activity is negatively modified by anionic phospholipids [62]
, it is conceivable that in conditions such as hy-8.1. eNOS percholesterolemia, the disruption in eNOS activity may be caused by alterations in the lipid surroundings. The The main source of endothelial NO, a crucial factor for association of eNOS with the resident coat protein of the normal functioning of the cardiovascular system, is caveolae (caveolin-1 and caveolin-3 in endothelial cells eNOS expressed by endothelial cells [87, 88] . Other celand myocytes respectively) is mediated by the scaffolding lular sources relevant to the cardiovascular system include domain in caveolin, and leads to inhibition of eNOS cardiac myocytes [89] and cardiac conduction tissue [90] .
activity [100] , apparently via functional interference with The particular properties of eNOS which enable it to CaM binding and electron transfer [101] . A similar inhib-21 perform its specialised functions include Ca sensitivity, itory association has recently been observed between and the posttranslational modifications which mediate eNOS and the bradykinin B2 receptor [102] . Interestingly, subcellular localisation. These enable the enzyme to rea putative consensus sequence for mediating the interaction spond not only to a variety of neurohormonal agents, but with caveolin is present not only in eNOS (350-358 in also to haemodynamic forces. In these respects, eNOS bovine eNOS) but also in the other two NOS isoforms differs significantly from the other isoforms, and this [103] . This sequence lies in the putative oxygenase / reducsection describes the molecular properties of the enzyme tase interaction surface suggested by the crystal structure which account for these specialised features.
[29], supporting the proposed role of interference with Although eNOS was often referred to earlier as constituelectron transfer. It is the disruption of this acylationtive NOS, a number of factors as diverse as hypoxia [91] , independent eNOS-caveolin complex and not as earlier estrogen [92] and exercise [93] are now known to alter its studies suggested depalmitoylation [104] which leads to expression. Since endothelial control of vascular tone is a the agonist-induced activation of eNOS [105] . sensitive and highly tuned process, these changes are likely to be immensely important to cardiovascular function, 8.2. nNOS particularly in pathophysiological situations. eNOS is 21 active, albeit sub-maximally, at the concentration of Ca
In addition to the well-studied role of NO in the process found in resting endothelial cells (around 100 nM) [40] , of penile erection [106], non-adrenergic non-cholinergic explaining the vasoconstricting effect of a NOS inhibitor relaxation occurs in all vascular smooth cells, as a result of on basal blood flow [94] . The enzyme is generally fully the widespread expression of nNOS in peripheral neurons 21 activated by an increase in intracellular Ca , resulting [107] . The regulation of nNOS activity is unique, with the 21 either from an influx of extracellular Ca , or from release subcellular localisation of the enzyme being mediated by a from intracellular stores. However, in a study using completely different mechanism to the fatty acylationstretched segments of artery [8] , shear stress-induced NO mediated membrane association of eNOS. nNOS is the production, which was dependent on tyrosine phosphorylalargest of the three isoforms due to the addition of a 300 21 tion, was independent of extracellular Ca . The mechaamino acid stretch at the N-terminus. This region contains nism behind this observation was suggested to be a change a PDZ domain (named after three of the proteins in which in the microenvironment of the protein, perhaps involving it was first described [108] , also called a discs-large pH changes.
homologous region (DHR) or GLGF amino acid repeat), The activation of eNOS can be induced by hormones which is an approximately 90-residue long protein-recognisuch as catecholamines and vasopressin, autacoids such as tion module responsible for the association of nNOS with bradykinin and histamine, and platelet-derived mediators other proteins containing this motif, including dystrophin such as serotonin and ADP, via receptor-mediated activaat the sarcolemmal membrane [109] and PSD-95, a tion of G proteins [95] . The activation of eNOS by channel-associated protein in the brain [110] . The Tyr77 mechanical forces including shear stress [96] and cyclic residue in the nNOS PDZ domain mediates selective strain [97] is also mediated through G protein activation binding to an Asp-X-Val consensus, which differs from the [98] . The subcellular targeting of eNOS plays a crucial role (Thr / Ser)-X-Val consensus favoured by PSD-95, and is in this receptor-mediated mechanism of activation, by present in glutamate and melatonin receptors [111] . Like localising the enzyme in the proximity of the signaling eNOS, nNOS is also inhibited by the association with molecules which mediate its activation [99] . This localisacaveolin [100] . This inhibitory interaction with caveolin-3 tion to the plasmalemmal caveolae is regulated by the in skeletal muscle can be mediated by two separate postranslational modifications at the N-terminal myriscaveolin domains [112] . toylation and palmitoylation sites which are unique to the In terms of the enzymatic function of nNOS, it appears endothelial isoform of NOS (see accompanying article by to differ from the other NOS isoforms by its readiness to Papapetropoulos et al., pp. 509-520, this issue). The catalyse the uncoupled oxidation of NADPH. Progress is distinctive lipid content of the caveolae is important to being made in understanding the mechanism of this their function, and, in light of the observation that NOS reaction (see Section 7) . Although this reaction may help to explain the damaging role of nNOS in ischaemia in the availability of substrate, particularly in the case of iNOS, brain [113] , the significance for nNOS-expressing cells can be regulated by changes in L-arginine uptake [125] , or outside the brain is not yet clear.
in the activities of argininosuccinate synthetase [126] or arginase [127] . BH availability is controlled largely by 4 8.3. iNOS GTP cyclohydrolase [128] . Regarding substrate levels, the fact that both the concentration of L-arginine in blood and The effects of iNOS in vivo are a result of its unique the intracellular L-arginine concentration [129, 130] expression. Under normal physiological conditions, iNOS seem to suggest that substrate availability should never be is unlikely to have much impact on the cardiovascular a limiting factor under normal conditions. However, system because of its low or absent expression, a concluseveral studies have shown that supplementation with Lsion which is supported by the lack of phenotype of arginine can have beneficial effects, e.g. it reversed the uninfected iNOS knockout mice [114] . However, iNOS increased adhesiveness of monocytes in hypercholesexpression can be induced by inflammatory mediators in terolemic humans [132] . One possible mechanism by most types of vascular cells, including endothelial cells which L-arginine mediates these effects may be to out- [115] , cardiac myocytes [116] , and smooth muscle cells compete the effects of the endogenous inhibitor, [117] , as well as macrophages [118] , which, as a result of asymmetrical dimethylarginine, which is increased in the high NO output, can have potentially damaging hypercholesterolemia [133] . Since high doses of arginine consequences. The expression of iNOS by macrophages can have additional effects which are unrelated to NO and smooth muscle cells in atherosclerotic lesions has been synthesis such as increasing the release of insulin taken as evidence for its detrimental role in atherosclerosis [134, 135] , it is important to show that the effects of [118] . Furthermore, iNOS expression is responsible for the arginine are stereospecific in order to claim that increased impairment in eNOS-derived NO production in vessels NOS activity is mediating the observed changes. treated with inflammatory mediators [119] . However, Alterations in the pathways governing substrate and iNOS expression may in some cases be protective, as cofactor availability can have a significant impact on the shown by the iNOS-mediated suppression of allograft outcome of NOS activity. Understanding these regulatory arteriosclerosis, via the prevention of intimal hyperplasia mechanisms will provide insights into both the physiologi- [120] . In contrast to the two constitutive isoforms, iNOS cal regulation of NOS activity as well as the reasons contains neither of the specific membrane-targeting sebehind the many pathophysiological states in which alteraquences. Despite this, it has been found to be membranetions in NO production are postulated to play a role. associated in human neutrophils [121] and mouse macrophages [122, 123] . However, the proportion of membranebound enzyme varies between cell type and species, with 10. Conclusion less than half of mouse macrophage iNOS being membrane-associated. The functional relevance of this associaThe complexity of NO biosynthesis is largely attributtion is not known.
able to the multi-featured nature of the enzyme itself. The three distinct isoforms of NOS therefore show Although much progress has recently been made into contrasting functions as a result of their sequence differelucidating the biochemistry of this dimeric, multidomain ences. Some of these lead to obvious structural changes, molecule, it will be clear from this review that the mystery such as the fatty acylation of eNOS, whereas others are is far from solved. Outstanding questions which have been more subtle, for example the tendency to uncouple discussed here include the role of BH and the nature of 4 NADPH oxidation. Understanding these differences will the NOS products in vivo. Despite the hints provided by enable us to exploit the unique features of each isoform, the crystal structure and substances like 4-amino-BH , the 4 permitting selective stimulation or inhibition as required. precise function of the cofactor is still a matter of debate. The continuing development of various BH analogues 4 should in the near future enable us to at last understand the 9. Control of NO synthase activity via substrate / full role of this cofactor in NOS function. In contrast, with cofactor regulation recent publications demonstrating the ability of eNOS and Although an in depth discussion on the topic is outside appears that the struggle to clarify the nature of the actual the scope of this article, the regulation of cofactor availaproducts of NOS is far from over. Similarly, despite bility in determining NOS activity deserves a mention growing evidence concerning the structural differences here. Apparent paradoxes of decreased protein expression which give the NOS isoforms their distinct functions, the in the face of increased NO production, as seen in LDLaim of exploiting these differences in order to selectively treated endothelial cells [124] , illustrate the necessity of modify NOS activity in an isoform-specific manner reunderstanding the global regulation of NOS activity. The mains a target for the future. 
